Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes

NCT03556631 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Probiotics

Interventions

DRUG: live combined Bifidobacterium and Lactobacillus Tablets

Sponsor

Shenzhen People's Hospital